Afatinib versus gefitinib as first-line treatment of patients with EGFR mutation-positive non-small-cell lung cancer (LUX-Lung 7): a phase 2B, open-label, randomised controlled trial
| Image |  |
|---|---|
| Description | scientific article published on 12 April 2016 |
| Author/s |
author: Tony Mok Janessa Laskin Ki Hyeong Lee Michael J. Boyer James Chih-Hsin Yang |
| Publication date | April 12, 2016 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |